|Articles|March 17, 2020

Sharing Best Practices for Successful Clinical Trials

A series written by The Michael J. Fox Foundation for Parkinson’s Research called Eye on Patient Advocacy, discusses how to increase the success of clinical research studies in areas like trial recruitment and retention.

Over a year ago, the staff of The Michael J. Fox Foundation for Parkinson’s Research (MJFF) began writing a series of articles, called Eye on Patient Advocacy. This series discusses how to increase the success of clinical research studies in areas like trial recruitment and retention using case studies from Parkinson's research. The six articles, on topics ranging from digital marketing to the importance of site selection, can be found compiled in a recent blog post by MJFF.

Read the blog post and series, here.

Related to this article

The Human Side of Clinical Trials: Why Fuzzy Mental Models Undermine Clinical Trial Execution
In Episode 3 of The Human Side of Clinical Trials, hosts Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., speak with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about why a well-written protocol doesn’t always translate into consistent execution, and how designing for the way people actually think and learn can reduce site burden and the need for costly unlearning.
© putilov_denis - © putilov_denis - stock.adobe.com
Real-time clinical trials require standardized digital data capture at the point of care through scaled eSource-EDC-EHR integration, but progress stalls because competing standards lack regulatory enforcement and one-off system integrations cannot scale beyond single studies without industry-wide alignment and legal clarity on data ownership.